Two evidence-based treatments dominate UK depression care: antidepressant drugs, especially SSRIs, and Cognitive Behavioural Therapy (CBT). NICE guidelines often recommend either, or a combination, depending on severity.
SSRIs (Selective Serotonin Reuptake Inhibitors)
Examples: fluoxetine (Prozac), sertraline, citalopram, escitalopram.
How they work (links to P2.B.2):
- After a presynaptic neuron fires, serotonin is released into the synapse and binds receptors on the postsynaptic neuron.
- Normally, the presynaptic neuron then reuptakes the serotonin to recycle it.
- SSRIs block the reuptake transporter — serotonin stays in the synapse longer, prolonging postsynaptic stimulation.
- Over weeks, downstream effects (neuroplasticity, neurogenesis in the hippocampus) drive symptom improvement.
Strengths:
- Wide evidence base (Kirsch & Sapirstein 1998 meta-analysis showed efficacy over placebo, especially for moderate-to-severe depression).
- Easy to administer; relatively cheap.
- Useful when severe depression makes therapy hard to engage with.
Weaknesses:
- Side effects: nausea, headache, sexual dysfunction, weight change. Discontinuation symptoms if stopped abruptly.
- Delayed effect: 4–6 weeks before full benefit; risk of suicide may briefly rise in young people in early weeks.
- Tackles symptoms not causes: relapse common after discontinuation.
- Effect size debated: Kirsch (2008) argued SSRIs offer little advantage over placebo for mild depression.
- Long-term effects less well studied.
Cognitive Behavioural Therapy (CBT)
Developed from Beck's cognitive theory (P2.PS.3). The therapist works with the client to:
- Identify negative automatic thoughts and underlying schemas.
- Challenge them — examining evidence for and against; testing alternative interpretations.
- Replace distortions with more balanced thinking.
- Pair with behavioural experiments — scheduling activities that disconfirm depressive predictions ("if I go to the gym I'll feel worse" → tested → contradicted).
Typical course: 12–20 weekly sessions, structured agenda, homework between sessions.
Strengths:
- Effects often outlast treatment — CBT changes thinking habits and reduces relapse compared with medication alone (Hollon et al., 2005).
- Evidence base from many RCTs; recommended by NICE.
- Empowers the client; addresses causes not just symptoms.
- Avoids drug side effects.
- Available digitally (computerised CBT) for mild-to-moderate cases.
Weaknesses:
- Requires effort, motivation and verbal/cognitive skills — can be hard for severely depressed clients to engage.
- Time-intensive (12+ sessions); waiting lists in NHS.
- Less effective for severe or psychotic depression as a sole treatment.
- Therapist quality varies.
SSRIs vs CBT — when to use which?
NICE-style guidance:
- Mild depression: psychological interventions first (CBT, behavioural activation). Drugs not usually first-line.
- Moderate depression: CBT or SSRI; combination if severe or persistent.
- Severe depression: usually combination of SSRI + CBT; possibly inpatient care.
Combination is usually more effective than either alone, especially long-term.
⚠Common mistakes— Common errors
- Saying SSRIs "cure" depression — they manage symptoms; relapse is common.
- Saying CBT is "just talking" — it is structured, goal-focused and includes between-session homework.
- Forgetting NICE/severity matching — the choice depends on severity.
AI-generated · claude-opus-4-7 · v3-deep-psychology